Results

Total Results: 892 records

Showing results for "end stage renal".

701. Meditation Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/meditation_executive.pdf
     January 01, 2014 - • Was attrition <20% at the end of treatment? … One trial specified that the researchers looked for toxicities of meditation to hematologic, renal, … Mindfulness training and stress reactivity in substance abuse: results from a randomized, controlled stage … Change in women’s diet and body mass following intensive intervention for early-stage breast cancer … effects of mindfulness-based stress reduction on psychosocial outcomes and quality of life in early-stage

702. Future Research Needs for Hematopoietic Stem-Cell Transplantation in the Pediatric Population (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children-future_research.pdf
     February 01, 2012 - Intensive multimodality therapy for patients with stage 4a metastatic retinoblastoma. … risk solid tumors Safety/Efficacy Study 12 4/1999- 9/2012 United States FU: Annually until end … Phase II treatment study 60 (ages 6 to 59 years) 9/1994 - End date not provided United States … weight) Systemic Lupus Erythematosus Disease Activity Index Lupus serology (ANA, dsDNA, C3, C4) Renal … Supportive care intervention 150 (75 per arm) 1/2004 – End date not reported United States

703. Translation of a C. difficile Treatment Clinical Pathway Into Machine-Readable Clinical Decision Support Artifacts Prototyped for Electronic Health Record Implementation (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-translation-c-diff-treatment-clinical-pathway.pdf
     November 01, 2019 - Matter Experts and Clinical Informaticists Improved Clinical Accuracy and Usability of the Final CDS End … To that end, this AHRQ EPC methods project had two primary aims: 1. … Development of Tools and an Environment for Conducting End User L3 and L4 Artifact Testing To Assess … In the software development lifecycle, this stage of testing is often referred to as “black box” testing … implementing a computerized clinical decision support system for medication dosing for patients with renal

704. Comparative Effectiveness Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
     January 01, 2006 - in 2-3 doses; Extended- release, 100-200 mg/day RA: Delayed- release, 100-200 mg/day in 3- 4 Renal … impairment(CrCl >25 mL/min) max 150 mg/day; Moderate renal impairment (CrCl l<25 mL/min) max 100 … (Give numbers at each stage of attrition.) … : No SS difference b/t lumiracoxib and NSAIDs for renal endpoint or serious liver AEs. … update 9/16/02 Pain reduction 2 placebo controlled trials provided pain intensity at baseline and end

705. Disposition of Comments_Comparative Effectiveness Review No. 262_Pharmacotherapy for Adults With Alcohol Use Disorder in Outpatient Settings: Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-262-pharmacotherapy-alcohol-disposition-comments.pdf
     November 07, 2023 - Page 32, line 45: Missing “placebo” from the end of the first sentence. … Expert #4 ES Page v line 49 As a clinician I do not find contraindication to acamprosate (severe renal … major decision maker in this section, or if it stays in, specify that the contraindication is severe renal … should be careful to respect contraindications of each individual medication (for acamprosate, severe renal … Public Comment #3 (APA) Introduction p. 4 table disulfiram Suggest changing "at the acetaldehyde stage

706. THE HCUP NATIONWIDE READMISSIONS DATABASE (NRD), 2013
     hcup-us.ahrq.gov/db/nation/nrd/NRD_Introduction_2013.jsp
     January 01, 2013 - Medicare patients younger than 65 include people who are disabled or who have been diagnosed with end-stage … renal disease or amyotrophic lateral sclerosis (ALS). … software packages that perform calculations for numerous statistics arising from the stratified, single-stage … Medicare patients under the age of 65 include people who are disabled or who have been diagnosed with end-stage … renal disease or amyotrophic lateral sclerosis (ALS).

707. Psn-Pdf (pdf file)
     psnet.ahrq.gov/node/49843/psn-pdf
     October 01, 2018 - In the end, clinicians realized that the patient had initially been misdiagnosed with sepsis and that … organ dysfunction, such as hypotension, elevated lactate, respiratory failure, altered mental status, renal … the patient described had laboratory evidence of inflammation (elevated white blood cell count) and end-organ … When patients present with circulatory shock or signs of end-organ dysfunction, empiric antibiotics

708. 2023 National Healthcare Quality and Disparities Report Appendixes (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2023-NHQDR-appendixes-ACDE.pdf
     January 01, 2023 - Quality and Disparities Report A-13 kidney failure who received a transplant within 3 years of date of renal … 1,000 hospital admissions with percutaneous coronary intervention, age 40 and over HCUP 2020 Adult end … stage renal disease patients who saw a nephrologist at least 12 months prior to initiation of renal … Patients with treated chronic kidney failure who received a transplant within 3 years of date of renal … (regional, distant stage, or local stage with tumor greater than 2 cm) per 100,000 women age 40 and

709. 2023 National Healthcare Quality and Disparities Report Appendixes (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2023-NHQDR-appendixes-ACDE-rev.pdf
     January 01, 2023 - Quality and Disparities Report A-13 kidney failure who received a transplant within 3 years of date of renal … 1,000 hospital admissions with percutaneous coronary intervention, age 40 and over HCUP 2020 Adult end … stage renal disease patients who saw a nephrologist at least 12 months prior to initiation of renal … Patients with treated chronic kidney failure who received a transplant within 3 years of date of renal … (regional, distant stage, or local stage with tumor greater than 2 cm) per 100,000 women age 40 and

710. Methods Applying AHRQ Quality Indicators to Healthcare Cost and Utilization Project (HCUP) Data for the Tenth (2012) NHQR and NHDR (pdf file)
     hcup-us.ahrq.gov/reports/methods/2012-02.pdf
     January 01, 2012 - QI measures generated for possible inclusion in the NHQR and NHDR are described in Table 1 at the end … For the list of data organizations that contribute to the HCUP databases, see Table 2 at the end of … poisonings, self-inflicted injury, trauma) from numerators and denominators, as shown in Table 7 at the end … neonates with a birth weight less than 500 gramsa), age less than 18 years PDI 02 Pressure ulcers – Stage … 0.5% mortality, excluding trauma, immunocompromised, and cancer patients PSI 3 Pressure ulcers – Stage

711. AHRQ Slide Template 2009 (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/topic-refinement.ppt
     March 01, 2010 - What is the risk of renal dysfunction, hyperkalemia, cough, and angioedema associated with the use of … The second question is, “What is the risk of renal dysfunction, hyperkalemia, cough, and angioedema associated … Many surrogate/intermediate end points have not been adequately validated. … Just because there is enough information to pool a myriad of intermediate end points does not mean that … This completes the topic refinement project and sets the stage for the next phase, in which the key questions

712. Disposition of Comments for Technical Brief 27 Patient Safety (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ambulatory-safety_disposition-comments.pdf
     October 19, 2016 - Thus my 1st several readings left me w/ a feeling that it seems to almost "end before it begins." … sentences, legible orders, medication list maintenance, some decision- support successes (allergies, renal … No response needed Peer Reviewer #5 Background I thought this set the stage nicely. … I assume that keeping them anonymous at this stage is standard practice, but it would help to have a … It is AHRQ practice to keep them anonymous at the draft stage.

713. Archived: Evidence Summary: Hepatitis C Virus Infection: Screening, 2004 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/hepatitis-c-virus-infection-screening-2004
     March 08, 2004 - We excluded studies of pregnant patients; children; and patients with occupational exposures, end-stage … Clinical outcomes that we evaluated were mortality, end-stage liver disease, cirrhosis, and hepatocellular … We excluded studies that focused only on patients with end-stage liver disease, cirrhosis, or hepatocellular … undergone transplantation were excluded, as were studies of pregnant patients, children, or those with end-stage … renal disease or HIV infection.

714. ahrq29a - Screening for Hepatitis C Virus Infection: A Review of the Evidence for the U.S. Preventive Services Task Force (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/We5A-uCMvX5qYeFukGgqks
     March 01, 2004 - We excluded studies of pregnant patients; children; and patients with occupational exposures, end-stage … Clinical outcomes that we evaluated were mortality, end-stage liver disease, cirrhosis, and hepatocellular … We excluded studies that focused only on patients with end-stage liver disease, cirrhosis, or hepatocellular … undergone transplantation were excluded, as were studies of pregnant patients, children, or those with end-stage … renal disease or HIV infection.

715. Chronic-Urinary-Retention Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research.pdf
     September 01, 2014 - the study questions, the EPC consulted a panel of Key Informants who represent subject experts and end-users … Therefore, in the end, study questions, design, methodological approaches, and/or conclusions do not … Because of their role as end-users, individuals with potential conflicts may be retained. … Open Label|Primary Purpose: Treatment NCT00878176 Sacral Neuromodulation Test With Bilateral First Stage … Patients with Non- obstructive Urinary Retention: A Pilot Study Urinary Retention Procedure: First stage

716. Archived: Evidence Summary: Prostate Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary43/prostate-cancer-screening-2012
     October 07, 2011 - What are the harms of treatment of early-stage or screening-detected prostate cancer? … Surveillance, Epidemiology, and End Results (SEER) program ( n =25,900) of men 65 to 80 years of age … comorbid conditions (diabetes, cardiovascular disease, respiratory disease, gastrointestinal disease, renal … 1: 29%  Stage 2: 40%  Stage 3: 31%  PSA < 10 µg/L: 22% PSA 11–29 µg/L: 28% PSA > 30 µg/L: 23% PSA unknown … prostate-specific antigen; RCT = randomized, controlled trial; SEER = Surveillance, Epidemiology, and End

717. e3iVR: Conference on Ethics in Investigational and Interventional Uses of Immersive VR - Final Report (pdf file)
     digital.ahrq.gov/sites/default/files/docs/citation/r13hs024833-gill-final-report-2017.pdf
     January 01, 2017 - Results: By the end of Day 2, the group of stakeholder representatives and subject matter experts produced … These talks set the stage for development of guidelines that address the needs of these priority populations … reality include but are not limited to (i) the training of health professionals (e.g., percutaneous renal … If recognition of biases and defective perceptions in VR does not occur, we could end up increasing

718. Collaborative Modeling of U.S. Breast Cancer Screening Strategies (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/nmcMhEwWT9BncBBBQQN6Uf
     December 01, 2015 - years, with exponential distribution using DCIS incidence data from the Surveillance, Epidemiology and End … On the other end of the spectrum, the model allows for another subset of tumors to be “aggressive” by … years to capture lifetime reductions in breast cancer mortality occurring years after the start (and end … Surveillance, Epidemiology and End Results Program (SEER): SEER*Stat Software. … )vascular disease; paralysis; diabetes 12% 13 Severe AIDS; mild or severe liver disease; chronic renal

719. Collaborative Modeling of U.S. Breast Cancer Screening Strategies (pdf file)
     www.uspreventiveservicestaskforce.org/Home/GetFile/1/16255/collabmodelingbc/pdf
     December 01, 2015 - years, with exponential distribution using DCIS incidence data from the Surveillance, Epidemiology and End … On the other end of the spectrum, the model allows for another subset of tumors to be “aggressive” by … years to capture lifetime reductions in breast cancer mortality occurring years after the start (and end … Surveillance, Epidemiology and End Results Program (SEER): SEER*Stat Software. … )vascular disease; paralysis; diabetes 12% 13 Severe AIDS; mild or severe liver disease; chronic renal

720. In Conversation With… Sharon K. Inouye, MD, MPH | PSNet
     psnet.ahrq.gov/perspective/conversation-sharon-k-inouye-md-mph
     December 01, 2012 - tried to get them to share what they were using with me because I really viewed that as a means to an end … delirium, some of them say things like delirium following alcohol withdrawal, or delirium following renal … They're a little hyponatremic, going into renal failure, and on medications that maybe the doctor has … brain function [ 5 ]), it is worth thinking about delirium as an "acute brain injury" similar to other end-organ … As with these other important end-organ injuries, delirium is a clinical event for which prevention and